TrialCancer medicine2020

Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin-induced peripheral neurotoxicity in stage II/III colorectal cancer.

De-Shen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.